PEDIATRICS Vol. 46 No. 1 July 1970, pp. 16-24
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Odell, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odell, G. B.

THE DISTRIBUTION AND TOXICITY OF BILIRUBIN

E. Mead Johnson Address 1969

Gerard B. Odell M. D.1

1 Department of Pediatrics, Johns Hopkins University School of Medicine, and the Harriet Lane Service of the Children's Medical and Surgical Center of the Johns Hopkins Hospital, Baltimore

I am very honored and grateful to have been selected as a recipient of an E. Mead Johnson Award. It is indeed flattering to have one's professional efforts receive such special recognition, and it is a moment to be savored for a lifetime. Although this distinction is awarded to me, it belongs to many; and, I wish to give public recognition to some of the persons who have made this occasion possible.

I was fortunate to have had my introduction into pediatrics at Yale under the gifted faculty of Dr. Grover F. Powers. It was the originality and scientific integrity of Dr. Daniel C. Darrow that served as a model for me in the application of basic science principles to the understanding of clinical problems. It was Dr. Robert E. Cooke who taught me at the laboratory bench that the application of a method requires a thorough understanding of what it can measure quantitatively and that duplicate analyses are not a sign of weakness. He also taught me that the best experiments to test a hypothesis are those designed to prove it wrong rather than yield results that are compatible with it. It has also been Bob's continuing interest and support over the subsequent years as Chairman of the Department of Pediatrics at Johns Hopkins that has provided me the freedom to pursue my interests in bilirubin. Behind the scenes, not willing to accept credit, is Dr. Harry H. Gordon who provided my initial research support and most of my knowledge of newborn infants.




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
J. T. Wilson
Caution with Phenobarbital
Clinical Pediatrics, December 1, 1971; 10(12): 684 - 687.
[PDF]